Baseline Charateristics.
| N 28 | |
|---|---|
| Clinical characteristics | |
| Female | 24 (86%) |
| Age* | 61.2 ± 13.2 |
| ACPA (+) | 19 (67,9%) |
| Erosions | 13 (46,4%) |
| Extra-articular manifestations | 8 (28,6%) |
| TJC* | 10,8 ± 5,4 |
| SJC * | 7,4 ± 4,6 |
| DAS28-CPR* | 5,4 ± 0,91 |
| High disease activity | 71,5% |
| Moderate disease activity | 23,8% |
| Low disease activity | 4,7% |
| Previous treatment | |
| bDMARD | 24 (86%) |
| N° of previous bDMARDs * | 3,9±2,2 |
| iTNF | 75% |
| No-iTNF | 67,9% |
(*) Mean ± SD